Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase II trial of pazopanib and weekly paclitaxel in metastatic urothelial cancer (UC). Srinivas, S., Narayanan, S., Harshman, L., Lam, A. P., Vaishampayan, U. N., Haas, D., Poushnejad, S., Pachynski, R. AMER SOC CLINICAL ONCOLOGY. 2014
View details for DOI 10.1200/jco.2014.32.4_suppl.299
View details for Web of Science ID 000335318100300